Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2017 Filed Jun 15, 2017 21:45 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionCommon Stock | 328 | $21.35 | $7,002.80 |
DisclosureSEC source: 0001553878-17-000036 · primary_doc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:59 UTC |
PYOTT DAVID E IDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000028 · edgardoc.xml · derivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 21:04 UTC |
STARR KEVIN PDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000035 · edgardoc.xml · derivative · entry 1 STARR KEVIN P · CIK 0001192603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 21:02 UTC |
SHARP PHILLIP ADirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000033 · edgardoc.xml · derivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 21:01 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000031 · edgardoc.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:59 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000029 · edgardoc.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:58 UTC |
PAUL STEVEN MDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000026 · edgardoc.xml · derivative · entry 1 PAUL STEVEN M · CIK 0001237564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:56 UTC |
Fanucci MarshaDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000024 · edgardoc.xml · derivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:55 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000022 · edgardoc.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:53 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000018 · edgardoc.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:54 UTC |
BONNEY MICHAEL WDirector
|
GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $71.99 | $0.00 |
DisclosureSEC source: 0001553878-17-000020 · edgardoc.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-06-01 Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 23:41 UTC |
Sanofi10% owner
|
PurchaseCommon Stock | 297,501 | $71.87 | $21,381,396.87 |
DisclosureSEC source: 0000899243-17-015022 · doc4.xml · nonDerivative · entry 1 Sanofi · CIK 0001121404 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via wholly-owned subsidiary, Genzyme Corp. Disclosed balance after: 10,554,134 F1 · shares: Purchase of shares in accordance with the terms of the investor agreement between Alnylam and Genzyme (a Sanofi company) dated February 27, 2014. Read SEC document |
| May 30, 2017 Filed May 31, 2017 21:22 UTC |
KEATING LAURIESVP, GC and Secretary
|
PurchaseCommon Stock | 11,500 | $65.35 | $751,502.00 |
DisclosureSEC source: 0001553878-17-000015 · primary_doc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Read SEC document |
| May 23, 2017 Filed May 25, 2017 22:39 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001553878-17-000014 · primary_doc.xml · derivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,994 Underlying: Common Stock · 11,000 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 23, 2017 Filed May 25, 2017 22:39 UTC |
Vaishnaw AkshayEVP, R&D
|
SaleCommon Stock | 11,000 | $75.00 | $825,000.00 |
DisclosureSEC source: 0001553878-17-000014 · primary_doc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,297 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. Read SEC document |
| May 23, 2017 Filed May 25, 2017 22:39 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionCommon Stock | 11,000 | $21.35 | $234,850.00 |
DisclosureSEC source: 0001553878-17-000014 · primary_doc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. Read SEC document |
| May 16, 2017 Filed May 17, 2017 22:45 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0001553878-17-000013 · primary_doc.xml · derivative · entry 6 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,625 shares Expires 2022-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2016. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 16, 2017 Filed May 17, 2017 22:45 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001553878-17-000013 · primary_doc.xml · derivative · entry 5 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2021-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2016. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 16, 2017 Filed May 17, 2017 22:45 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 9,375 | $70.00 | $656,250.00 |
DisclosureSEC source: 0001553878-17-000013 · primary_doc.xml · nonDerivative · entry 3 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2016. Read SEC document |
| May 16, 2017 Filed May 17, 2017 22:45 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 3,750 | $7.10 | $26,625.00 |
DisclosureSEC source: 0001553878-17-000013 · primary_doc.xml · nonDerivative · entry 2 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2016. Read SEC document |
| May 16, 2017 Filed May 17, 2017 22:45 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 5,625 | $18.66 | $104,962.50 |
DisclosureSEC source: 0001553878-17-000013 · primary_doc.xml · nonDerivative · entry 1 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2016. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,750 | $0.00 Strike: $31.39 | $0.00 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · derivative · entry 7 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,750 shares Expires 2017-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · derivative · entry 6 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,994 Underlying: Common Stock · 11,000 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
SaleCommon Stock | 11,000 | $65.00 | $715,000.00 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · nonDerivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,297 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
Exercise / conversionCommon Stock | 11,000 | $21.35 | $234,850.00 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · nonDerivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
SaleCommon Stock | 32,750 | $65.00 | $2,128,750.00 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,297 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:31 UTC |
Vaishnaw AkshaySVP, R&D
|
Exercise / conversionCommon Stock | 32,750 | $31.39 | $1,028,022.50 |
DisclosureSEC source: 0001553878-17-000012 · primary_doc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. 32,750 and 11,000 options exercised and sold by the reporting person were due to expire on December 11, 2017 and December 8, 2018, respectively. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:32 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $31.29 | $0.00 |
DisclosureSEC source: 0001553878-17-000009 · edgardoc.xml · derivative · entry 5 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:32 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 4,829 | $40.16 | $193,932.64 |
DisclosureSEC source: 0001553878-17-000009 · edgardoc.xml · nonDerivative · entry 3 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,795 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. F3 · price: Sale prices ranged from $40.10 to $40.24 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:32 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 20,171 | $39.72 | $801,192.12 |
DisclosureSEC source: 0001553878-17-000009 · edgardoc.xml · nonDerivative · entry 2 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,624 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. F2 · price: Sale prices ranged from $39.09 to $40.08 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:32 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionCommon Stock | 25,000 | $31.29 | $782,250.00 |
DisclosureSEC source: 0001553878-17-000009 · edgardoc.xml · nonDerivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 21:10 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $31.39 | $0.00 |
DisclosureSEC source: 0001553878-17-000007 · edgardoc.xml · derivative · entry 4 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 21:10 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 15,000 | $37.95 | $569,250.00 |
DisclosureSEC source: 0001553878-17-000007 · edgardoc.xml · nonDerivative · entry 2 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,795 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. F2 · price: Sale prices ranged from $37.31 to $38.25 Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 21:10 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionCommon Stock | 15,000 | $31.39 | $470,850.00 |
DisclosureSEC source: 0001553878-17-000007 · edgardoc.xml · nonDerivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 21:12 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001553878-17-000004 · edgardoc.xml · derivative · entry 5 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 21:12 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 6,200 | $38.20 | $236,840.00 |
DisclosureSEC source: 0001553878-17-000004 · edgardoc.xml · nonDerivative · entry 3 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,795 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. F3 · price: Sale prices ranged from $38.09 to $38.50 Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 21:12 UTC |
SHARP PHILLIP ADirector
|
SaleCommon Stock | 8,800 | $37.57 | $330,616.00 |
DisclosureSEC source: 0001553878-17-000004 · edgardoc.xml · nonDerivative · entry 2 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,995 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. F2 · price: Sale prices ranged from $37.07 to $38.06 Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 21:12 UTC |
SHARP PHILLIP ADirector
|
Exercise / conversionCommon Stock | 15,000 | $15.91 | $238,650.00 |
DisclosureSEC source: 0001553878-17-000004 · edgardoc.xml · nonDerivative · entry 1 SHARP PHILIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:22 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,340 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0001553878-17-000002 · primary_doc.xml · derivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,641 Underlying: Common Stock · 1,340 shares Expires 2022-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 21:22 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,340 | $18.66 | $25,004.40 |
DisclosureSEC source: 0001553878-17-000002 · primary_doc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 22:33 UTC |
Mason MichaelVP, Finance and Treasurer
|
GrantRestricted Stock Units · Derivative | 8,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001325812-17-000002 · edgardoc.xml · derivative · entry 1 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,502 Underlying: Common Stock · 8,502 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on December 30, 2017. F2 · derivative.expiration_date: The restricted stock units vest in full on December 30, 2017. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,356 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · derivative · entry 8 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,994 Underlying: Common Stock · 4,356 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,019 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · derivative · entry 7 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,981 Underlying: Common Stock · 4,019 shares Expires 2022-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,172 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · derivative · entry 6 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,913 Underlying: Common Stock · 1,172 shares Expires 2019-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Tax withholdingCommon Stock | 5,000 | $37.44 | $187,200.00 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · nonDerivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,297 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionCommon Stock | 4,356 | $21.35 | $93,000.60 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · nonDerivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionCommon Stock | 4,019 | $18.66 | $74,994.54 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:30 UTC |
Vaishnaw AkshayEVP, R&D
|
Exercise / conversionCommon Stock | 1,172 | $16.43 | $19,255.96 |
DisclosureSEC source: 0001553878-17-000001 · primary_doc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 21:20 UTC |
Gros David-Alexandre CSVP, Chief Business Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-16-000110 · edgardoc.xml · derivative · entry 1 Gros David-Alexandre C · CIK 0001644489 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-20 F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 21:19 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-16-000105 · edgardoc.xml · derivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-20 F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.